FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

624911000001107: Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16601301000001119 Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16601401000001110 Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Is a Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Is a Naproxen 250mg tablets true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Naproxen false Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Is a Arthrosin true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) 84 tablet Is pack of False Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) 84 tablet Has AMP True Arthrosin 250 tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start